A novel diffuse large B-cell lymphoma-associated cancer testis antigen encoding a PAS domain protein

British Journal of Cancer

Volumn 91, Issue 1, 2004, Pages 141-149

  Liggins, A P ^a   Brown, P J ^a   Asker, K ^a   Pulford, K ^a   Banham, A H ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cancer testis antigen; Lymphoma; PAS domain; SEREX

Indexed keywords

AMINO ACID; ANTIBODY; CANCER TESTIS ANTIGEN; CANCER VACCINE; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; COMPLEMENTARY DNA; LEUCINE ZIPPER PROTEIN; MESSENGER RNA; PROTEIN; PROTEIN BCL 6; PROTEIN MUM1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; PASK PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; SPANXC PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; B CELL LYMPHOMA; CANCER CELL CULTURE; CANCER PATIENT; CONTROLLED STUDY; DNA SPLICING; GENETIC CODE; GENETIC PROCEDURES; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; INTRON; NUCLEOTIDE SEQUENCE; PERIODIC ACID SCHIFF STAIN; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLID TUMOR; ANTIBODY PRODUCTION; GENE EXPRESSION PROFILING; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LARGE CELL LYMPHOMA; MALE; MOLECULAR GENETICS; TESTIS;

AMINO ACID SEQUENCE; ANTIBODY FORMATION; ANTIGENS, NEOPLASM; CANCER VACCINES; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TESTIS;

EID: 3342991899     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601875     Document Type: Article

References (33)

1. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson Jr J, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503-511
2. Bea S, Ribas M, Hernandez JM, Bosch F, Pinyol M, Hernandez L, Garcia JL, Flores T, Gonzalez M, Lopez-Guillermo A, Piris MA, Cardesa A, Montserrat E, Miro R, Campo E (1999) Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood 93: 4365-4374
3. Bernhard H, Salazar L, Schiffman K, Smorlesi A, Schmidt B, Knutson KL, Disis ML (2002) Vaccination against the HER-2/neu oncogenic protein. Endocr Relat Cancer 9: 33-44
4. Brichard V, Van Pel A, Wölfel T, Wölfel C, De Plaen E, Lethé B, Coulie P, Boon T (1993) The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 178: 489-495
5. Caballero OL, de Souza SJ, Brentani RR, Simpson AJ (2001) Alternative spliced transcripts as cancer markers. Dis Markers 17: 67-75
6. Cooper DL (1995) Retention of CD44 introns in bladder cancer: understanding the alternative splicing of pre-mRNA opens new insights into the pathogenesis of human cancers. J Pathol 177: 1-3
7. Coulie PG, Karanikas V, Colau D, Lurquin C, Landry C, Marchand M, Dorval T, Brichard V, Boon T (2001) A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3. Proc Natl Acad Sci USA 98: 10290-10295
8. Dioum EM, Rutter J, Tuckerman JR, Gonzalez G, Gilles-Gonzalez M-A, McKnight SL (2002) NPAS2: A gas-responsive transcription factor. Science 298: 2385-2387
9. Dunlap JC, Loros JJ, Liu Y, Crosthwaite SK (1999) Eukaryotic circadian systems: cycles in common. Genes Cells 4: 1-10
10. Elferink CJ (2003) Aryl hydrocarbon receptor-mediated cell cycle control. Prog Cell Cycle Res 5: 261-267
11. Goyns MH, Hammond DW, Harrison CJ, Menasce LP, Ross FM, Hancock BW (1993) Structural abnormalities of the X-chromosome in non-Hodgkin's-lymphoma. Leukemia 7: 848-852
12. Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Müller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan W (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103: 275-282
13. Hayashibara T, Yamada Y, Mori N, Harasawa H, Sugahara K, Miyanishi T, Kamihira S, Tomonaga M (2003) Possible involvement of aryl hydrocarbon receptor (AhR) in adult T-cell leukemia (ATL) leukemogenesis: constitutive activation of AhR in ATL. Biochem Biophys Res Commun 300: 128-134
14. Huang S, Preuss K-D, Xie X, Regitz E, Pfreundschuh M (2002) Analysis of the antibody repertoire of lymphoma patients. Cancer Immunol Immunother 51: 655-662
15. Jaffe SE, Harris LN, Stein H, Wardiman WJ (2001) WHO Classification: Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press
16. Jäger D, Jäger E, Knuth A (2001) Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer. J Clin Pathol 54: 669-674
17. Kozak M (1987) At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J Mol Biol 196: 947-950
18. Liggins AP, Guinn BA, Hatton CS, Pulford K, Banham AH (2004) Serologic detection of diffuse large B-cell lymphoma-associated antigens. Int J Cancer 110: 563-569
19. Liu JW, Chandra D, Tang SH, Chopra D, Tang DG (2002) Identification and characterization of Bimgamma, a novel proapoptotic BH3-only splice variant of Bim. Cancer Res 62: 2976-2981
20. McInerney EM, Rose DW, Flynn SE, Westin S, Mullen T-M, Krones A, Inostroza J, Torchia J, Nolte RT, Assa-Munt N, Milburn MV, Glass CK, Rosenfeld MG (1998) Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Dev 12: 3357-3368
21. Nishikawa H, Tanida K, Ikeda H, Sakakura M, Miyahara Y, Aota T, Mukai K, Watanabe M, Kuribayashi K, Old LJ, Shiku H (2001) Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity. Proc Natl Acad Sci USA 98: 14571-14576
22. Preuss KD, Zwick C, Bormann C, Neumann F, Pfreundschuh M (2002) Analysis of the B-cell repertoire against antigens expressed by human neoplasms. Immunol Rev 188: 43-50
23. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Staudt LM (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346: 1937-1947
24. Sahin U, Türeci Ö, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M (1995) Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 92: 11810-11813
25. Salomon-Nguyen F, Della-Valle V, Mauchauffe M, Busson-Le Coniat M, Ghysdael J, Berger R, Bernard OA (2000) The t(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion. Proc Natl Acad Sci USA 97: 6757-6762
26. Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen Y-T (2002) Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 188: 22-32
27. The Non-Hodgkin's Lymphoma Classification Project (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 89: 3909-3918
28. Triezenberg SJ (1995) Structure and function of transcriptional activation domains. Curr Opin Genet Dev 5: 190-196
29. Türeci Ö, Sahin U, Zwick C, Neumann F, Pfreundschuh M (1999) Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens. Hybridoma 18: 23-28
30. van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643-1647
31. Vineis P, Masala G, Costantini AS (1999) Does a gene in the Xq28 region increase the risk of non-Hodgkin's lymphomas? Working group for the Epidemiology of Hematolymphopoietic Malignancies in Italy. Ann Oncol 10: 471-473
32. Woodson K, Mason J, Choi S-W, Hartman T, Tangrea J, Virtamo J, Taylor PR, Albanes D (2001) Hypomethylation of p53 in peripheral blood DNA is associated with the development of lung cancer. Cancer Epidemiol Biomarkers Prev 10: 69-74
33. Xie X, Wacker HH, Huang S, Regitz E, Preuss KD, Romeike B, Parwaresch R, Tiemann M, Pfreundschuh M (2003) Differential expression of cancer testis genes in histological subtypes of non-Hodgkin's lymphomas. Clin Cancer Res 9: 167-173